Curcuma longa (turmeric) or its active ingredients for osteoarthritis (Protocol)

Ivan  Shirinsky; Valery Shirinsky; Katerina Filatova; null Zeyu Yu; Yuan Chi; Jacqueline  Thompson; C M Bleakley

doi:https://doi.org/10.1002/14651858.CD014683

Curcuma longa (turmeric) or its active ingredients for osteoarthritis (Protocol)

Ivan Shirinsky, Valery Shirinsky, Katerina Filatova, Zeyu Yu, Yuan Chi, Jacqueline Thompson, C M Bleakley

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

4 Downloads (Pure)

Abstract

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.

Original language	English
Article number	CD014683
Number of pages	15
Journal	Cochrane Database of Systematic Reviews
Volume	2021
Issue number	7
DOIs	https://doi.org/10.1002/14651858.CD014683
Publication status	Published (in print/issue) - 12 Jul 2021

Bibliographical note

Funding Information:
The methods section is based on the standard Cochrane Musculoskeletal Group Protocol Template. Peer reviewer Dr Benny Antony Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania and Ms Maureen Smith, Cochrane Consumer, are acknowledged.

Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.1002/14651858.CD014683

Shirinsky_et_al-2021-Cochrane_Database_of_Systematic_ReviewsFinal published version, 212 KB

Cite this

@article{e16a83bcdde841a2bdd4bf9deb238f1c,

title = "Curcuma longa (turmeric) or its active ingredients for osteoarthritis (Protocol)",

abstract = "Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.",

author = "Ivan Shirinsky and Valery Shirinsky and Katerina Filatova and {Zeyu Yu} and Yuan Chi and Jacqueline Thompson and Bleakley, {C M}",

note = "Funding Information: The methods section is based on the standard Cochrane Musculoskeletal Group Protocol Template. Peer reviewer Dr Benny Antony Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania and Ms Maureen Smith, Cochrane Consumer, are acknowledged. Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = jul,

day = "12",

doi = "https://doi.org/10.1002/14651858.CD014683",

language = "English",

volume = "2021",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley & Sons, Inc.",

number = "7",

}

TY - JOUR

T1 - Curcuma longa (turmeric) or its active ingredients for osteoarthritis (Protocol)

AU - Shirinsky, Ivan

AU - Shirinsky, Valery

AU - Filatova, Katerina

AU - Zeyu Yu, null

AU - Chi, Yuan

AU - Thompson, Jacqueline

AU - Bleakley, C M

N1 - Funding Information: The methods section is based on the standard Cochrane Musculoskeletal Group Protocol Template. Peer reviewer Dr Benny Antony Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania and Ms Maureen Smith, Cochrane Consumer, are acknowledged. Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2021/7/12

Y1 - 2021/7/12

N2 - Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.

AB - Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.

UR - https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014683/information#versionTable

UR - http://www.scopus.com/inward/record.url?scp=85110472027&partnerID=8YFLogxK

U2 - https://doi.org/10.1002/14651858.CD014683

DO - https://doi.org/10.1002/14651858.CD014683

M3 - Article

SN - 1469-493X

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 7

M1 - CD014683

ER -

Curcuma longa (turmeric) or its active ingredients for osteoarthritis (Protocol)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this